Literature DB >> 11851648

Long-term suppression of viral replication despite low plasma saquinavir concentrations in the CHEESE Study.

Rolf P G van Heeswijk, James W T Cohen Stuart, David M Burger, Jos H Beijnen, Jan C C Borleffs, Richard M W Hoetelmans.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 11851648      PMCID： PMC1874293          DOI： 10.1046/j.1365-2125.2002.01530.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  4 in total

Review 1.  The role of therapeutic drug monitoring in treatment of HIV infection.

Authors:  D J Back; S H Khoo; S E Gibbons; C Merry
Journal:  Br J Clin Pharmacol       Date:  2001-04       Impact factor: 4.335

2.  Simultaneous quantitative determination of the HIV protease inhibitors amprenavir, indinavir, nelfinavir, ritonavir and saquinavir in human plasma by ion-pair high-performance liquid chromatography with ultraviolet detection.

Authors:  R P van Heeswijk; R M Hoetelmans; R Harms; P L Meenhorst; J W Mulder; J M Lange; J H Beijnen
Journal:  J Chromatogr B Biomed Sci Appl       Date:  1998-11-20

3.  Randomized trial comparing saquinavir soft gelatin capsules versus indinavir as part of triple therapy (CHEESE study).

Authors:  J W Cohen Stuart; R Schuurman; D M Burger; P P Koopmans; H G Sprenger; J R Juttmann; C Richter; P L Meenhorst; R M Hoetelmans; F P Kroon; B Bravenboer; D Hamann; C A Boucher; J C Borleffs
Journal:  AIDS       Date:  1999-05-07       Impact factor: 4.177

4.  Treatment with lamivudine, zidovudine, or both in HIV-positive patients with 200 to 500 CD4+ cells per cubic millimeter. North American HIV Working Party.

Authors:  J J Eron; S L Benoit; J Jemsek; R D MacArthur; J Santana; J B Quinn; D R Kuritzkes; M A Fallon; M Rubin
Journal:  N Engl J Med       Date:  1995-12-21       Impact factor: 91.245
  4 in total
  2 in total

1.  Intracellular accumulation of human immunodeficiency virus protease inhibitors.

Authors:  Saye H Khoo; Patrick G Hoggard; Ian Williams; E Rhiannon Meaden; Philippa Newton; Edmund G Wilkins; Alan Smith; John F Tjia; Judy Lloyd; Kevin Jones; Nick Beeching; Peter Carey; Barry Peters; David J Back
Journal:  Antimicrob Agents Chemother       Date:  2002-10       Impact factor: 5.191

2.  Intracellular and plasma pharmacokinetics of saquinavir-ritonavir, administered at 1,600/100 milligrams once daily in human immunodeficiency virus-infected patients.

Authors:  Jennifer Ford; Marta Boffito; Adrian Wildfire; Andrew Hill; David Back; Saye Khoo; Mark Nelson; Graeme Moyle; Brian Gazzard; Anton Pozniak
Journal:  Antimicrob Agents Chemother       Date:  2004-07       Impact factor: 5.191
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.